Williamson Robert F III's Form 4 filing
Perspective Therapeutics, Inc.CATX · filed Dec 19, 2023
- Accession no.
- 0001437749-23-034933
- Filed
- Dec 19, 2023, 7:10 PM ET
- Trade date
- Dec 18-19, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $6.98K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Williamson Robert F IIICIK 0001397331 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2023 | Common Stock | PPurchaseAcquired | +10,000 | $0.26 | +$2,600 | 10,000 | Direct | |
| Dec 19, 2023 | Common Stock | PPurchaseAcquired | +13,680 | $0.32 | +$4,377.6 | 23,680 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.